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AN INSIGHT INTO GAIT COMPLEX MEDIATED 
TRANSLATIONAL SILENCING 
 
PURVI KAPASI 
 
ABSTRACT 
 
Transcript-specific translational control restricts macrophage inflammatory gene 
expression. The pro-inflammatory cytokine IFN-γ induces the phosphorylation of human 
ribosomal protein L13a and its subsequent release from 60S ribosome. L13a is a 
component of the interferon-gamma-activated inhibitor of translation (GAIT). The GAIT 
complex binds a defined element in the 3’-untranslated region (UTR) of ceruloplasmin 
(Cp) mRNA and causes delayed silencing of translation. In this research, we elucidate the 
molecular mechanism underlying L13a translational silencing activity. L13a mediates 
translational silencing particularly, when driven by internal ribosome entry sites (IRESs) 
that requires the initiation factor eIF4G, but is resistant to silencing when driven by 
eIF4F- independent IRESs. This demonstrates a critical role of the scaffold protein – 
eIF4G. Global inhibition of protein synthesis by targeting eIF4G is well appreciated in 
virus infection and apoptosis; however interaction of L13a with eIF4G blocks the 43S 
complex recruitment showing a unique role of eIF4G in gene specific translational 
silencing. 
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CHAPTER I 
BACKGROUND AND INFORMATION 
 
TRANSLATIONAL CONTROL OF GENE EXPRESSION 
 Translational Control is an important mechanism of post-transcriptional 
regulation. It offers a range of response levels even in the presence of a constant amount 
of mRNA. Translational regulation can be broadly divided into global and transcript 
specific translational control. In global translational control most cellular transcripts are 
affected whereas in transcript specific translational control cellular RNA – binding 
protein/s bind to the transcript and inhibit the protein synthesis. In eukaryotes, initiation 
is the rate – limiting step of translation and is often the target of control. Translation 
initiation is the process of ribosome assembly on mRNA (1) (2) (3). Initiation begins with 
the assembly of the hetrotrimeric eIF4F complex on the 5’UTR of mRNA. The eIF4F 
complex contains a cap binding protein eIF4E, RNA – dependent helicase eIF4A and its 
cofactor eIF4B, and a scaffold protein eIF4G. eIF4G is the backbone of the complex as it 
binds to both cap binding protein eIF4E and the RNA helicase eIF4A. Moreover, it also 
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binds to poly (A) tail binding protein – PABP which facilitates the interaction of 3’ poly 
(A) tail and 5’ cap making the transcript circular via end – to – end interaction (4). The 
43S pre – initiation complex contains multisubunit eIF3 complex, small ribosomal 
subunit 40S, eIF1/eIF1A and a pre-charged ternary complex of eIF2, GTP and initiator 
met-tRNA. This 43S complex is recruited to the mRNA by interaction of eIF3 with 
eIF4G of eIF4F complex (5). The complex then scans the 5’UTR to identify the AUG 
initiation codon. Codon recognition triggers hydrolysis of eIF2 and eIF5B – bound GTP 
and permits joining of the 60S ribosomal subunit to form an elongation competent 80S 
complex that can extend the peptide chain (fig 1).  
Fig1. Protein Translation: Eukaryotic protein translation showing all the initiation factors, 
recruitment of 43S complex on mRNA and joining of 60S and 80S ribosomal subunit 
 
CERULOPLASMIN 
Ceruloplasmin (Cp) is an inflammatory, acute-phase plasma protein made by 
hepatocytes in the liver and by activated monocytes/macrophages (6).  It is a 132kDa 
monomer with 7 copper atoms per molecule, and accounts for nearly about 95% of the 
circulating copper in healthy adult humans. Though its physiological function is 
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uncertain, experimental evidences from several laboratories suggests its role in 
bactericidal activity, coagulation, iron homeostasis, vascular relaxation and defense 
against oxidant stress and lipoprotein oxidation (7). Cp induces oxidation of low density 
lipoprotein (LDL) (8) (9) (10), which is considered to be a critical event during 
atherogenesis.  Cp is an acute phase protein and its high concentration in the serum has 
been shown to pose an independent risk factor for atherosclerosis (11) (12). The synthesis 
of Cp, a copper-containing protein in monocytes is regulated by the inflammatory 
cytokine IFN-  (13). Enhanced production of Cp by the activated monocytes-
macrophages may be due to an inflammatory response. The precise regulation of the 
synthesis of Cp by activated monocytes–macrophages is critical because any defects in 
regulation may lead to accumulation of Cp protein. Series of studies from our laboratory 
have shown that monocytes have an endogenous mechanism to terminate the IFN-  
induced Cp synthesis at the level of translation (14) and a ribosomal protein L13a was 
identified as a molecular switch for this silencing (15). 
Recently new evidences have started to emerge showing translational control may 
play a key role in the resolution of cellular inflammation. For example 15- Lipoxygenase, 
a pro-atherogenic molecule (16) is translationally silenced by binding of heterogeneous 
ribonuclear proteins (hnRNP) K and E1 to the DICE element of 3’UTR, which prevents 
the joining of 60S ribosomal subunit (17) (18). Similarly, using genetic and biochemical 
approaches our group discovered a novel pathway showing the translational silencing of 
Cp. Previous experimental studies showed that Cp protein synthesis is induced in 
response to pro-inflammatory cytokine IFN- , but the synthesis stops after about 16 
hours, even in the presence of abundant Cp mRNA. These studies led to the identification 
of four protein constituents of the Interferon Gamma Activated Inhibitor of Translation 
(GAIT) complex as ribosomal protein – L13a (15), Glutamyl-prolyl-tRNA synthetase 
(EPRS), NS-1 associated protein-1 (NSAP-1) and glyceraldehydes 3- phosphate 
dehydrogenase (GAPDH) (19). The complex binds to a specific element called as GAIT 
element in the 3’UTR of Cp mRNA. A 29 nt, GAIT element in the Cp 3’-untranslated 
region is necessary for the IFN-γ mediated translational silencing of ceruloplasmin and is 
sufficient to convey the silencing response to a heterologus transcript. We have also 
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shown that translational silencing of Cp requires the essential elements of mRNA 
circularization, i.e., the poly(A) tail, eukaryotic initiation factor (eIF) 4G or poly(A) 
binding protein (PABP). In IFN-  induced monocytic cells, L13a is phosphorylated and 
released from 60S ribosomal subunit. Phosphoryation of L13a is required for translational 
silencing activity because the silencing activity is sensitive to phosphatase. The free P- 
L13a incorporates into the GAIT complex that binds to the GAIT element thereby 
inhibiting the protein synthesis of Cp (fig 2). In addition, recombinant L13a expressed in 
E.coli in unphosphorylated form is inactive; however when the same protein expressed in 
baculovirus in phosphorylated form has been found to be fully active for translational 
silencing in vitro translation assay. My research focuses on elucidating the molecular 
mechanism underlying the translational silencing activity of this large ribosomal protein - 
L13a. 
            
Fig 2: Schematic representation of L13a being phosphorylated, released and binding to 
GAIT element (Mazumder et al., 2006, ref # 6).  
To elucidate the silencing mechanism of P-L13a, we hypothesized the following potential 
mechanisms (fig 3): 
(i) P-L13a blocks the recruitment of 43S pre-initiation complex on eIF4F  
(ii) P-L13a prevents the scanning of 43S complex to the initiation codon 
(iii)P-L13a blocks the joining of 60S ribosomal subunit 
(iv) P-L13a inhibits the function of eIF4F assembly 
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Fig 3: Schematic representation of different possibilities of GAIT complex mediated          
silencing.  
Our basic findings were that P-L13a inhibits the formation of 48S pre-initiation 
complex on the GAIT element containing RNA in a Poly(A) dependent manner. Also, P-
L13a binds the C-terminal domain of translation initiation factor eIF4G, thereby blocking 
the recruitment of eIF3 containing 43S complex. This exhibits a unique role of eIF4G in 
gene specific translation silencing. Moreover, the results suggests that eIF4G fragments 
containing the eIF3 binding site can also bind L13a indicating that eIF3 andL13a share 
the same or neighboring binding sites on eIF4G (20). 
 
SIGNIFICANCE OF THE FINDINGS 
Increasing evidences suggests the potential role of IFN-γ in the pathogenesis of 
atherosclerosis. For example: IFN-γ can stimulate the expression of VCAM-1, MHC-II, 
lipoprotein receptors and tissue factor, all potential pro-atherogenic molecules (21) (22) 
(23). Monocyte chemoattractant protein (MCP)-1 a pro-atherogenic factor, critical in 
development of atherosclerosis is chemotactic for monocytes and T-cells, and its 
expression is induced dramatically by IFN-γ (24). Genetic studies in gene knock out mice 
are also consistent with IFN-γ as a pro-atherogenic cytokine (25). In a model of allogenic 
transplantation, genetic absence of IFN-γ markedly reduces the extent of intimal 
expansion (26). In apoE knockout mouse, a genetic model of cholesterol-induced 
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atherosclerosis, targeted disruption of IFN-γ  receptor gene that results in reduced 
atherosclerosis (27). The molecular mechanisms underlying IFN-γ induced 
atherosclerosis are unknown. We have shown that the synthesis of Ceruloplasmin (Cp), a 
copper-containing protein in monocytes, is regulated by IFN-γ (28), while others have 
shown that Cp is required for LDL oxidation by these cells (29) (30). In addition, Cp is 
an inflammatory protein and its inflammatory response may enhance the production of 
Cp by the activated monocytes-macrophages. 
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CHAPTER II 
MATERIALS AND METHODS 
 
 
Reagents 
RRL, methionine-free amino acids, and RNasin were from Promega (Madison, 
WI). Shrimp alkaline phosphatase, reverse transcriptase, Taq polymerase, and restriction 
enzymes were from Fermentas (Hanover, MD). SP6 Message Machine kit for in vitro 
transcription was from Ambion (Austin, TX). Translation grade [35S]methionine and 
transcription grade [a-32P]UTP were from Amersham (Piscataway, NJ). Cycloheximide, 
GMP-PNP, and all other reagents were from Sigma (St.Louis, MO). Rabbit anti-peptide 
polyclonal antibody against human L13a was purified on a peptide column (44). Anti-
eIF4G antibodies were from Simon Morley and Matthias Hentze. Anti-eIF4A antibody 
was provided by Hans Trachsel and Michael Altmann. Anti-eIF3 antibody was a gift 
from John Hershey. Anti-eIF4E was purchased from Abcam (Cambridge, MA). HRV-2A 
protease was from Tim Skern. Anti-Flag and anti-HA antibodies were from Sigma and 
Roche, respectively. 
 
Plasmid Construction 
Construction of the plasmids PSP64-Luc-GAIT-poly(A) and PSP64-Luc-GAIT 
(mut.)-poly(A) were described previously (19). These plasmids were modified and used 
to generate capped, poly(A)-tailed (A50) RNAs m7G-Luc-GAITpoly(A) and m7G-Luc-
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GAIT (mut.)-poly(A). IRES-containing plasmids were made by PCR amplification of nt 
265-828 of EMCV genome using pGEM-Cat-EMCV-Luv (from Graham Belsham), nt 
40-373 of HCV genome using pHCV(40-373).NS from Tatyana Pestova (35), and nt 
6029-6219 of CrPV genome using pCup1 LEU2 IGR URA3 from Peter Sarnow. PCR 
products containing IRES sequences were cloned into Pst1 and BamH1 sites of PSP64-
Luc-GAIT-poly(A) and PSP64-Luc-GAIT (mut.)-poly(A) (19) to give plasmids 
EMCV(or HCV or CrPV)-Luc-GAIT-poly(A) and EMCV(or HCV or CrPV)-Luc-GAIT 
(mut.)-poly(A). These plasmids were used to generate RNAs containing ApppG at the 5’ 
cap.Plasmids PSP64-α-globin-GAIT-poly(A)50 and PSP64-α-globin-GAIT (mut.)-
poly(A)50 were made by PCR amplification of the 429-nt α-globin fragment from 
PHST101, excision of Luc, and cloning into the BamH1 and Stu1 sites of PSP64-Luc-
GAIT-poly(A) and PSP64-Luc-GAIT (mut.)-poly(A) (19). These plasmids were used to 
generate m7G-α-globin-GAIT-poly(A)50 and m7G-α-globin-GAIT (mut.)-poly(A)50 
RNAs. GST-fusion proteins containing specific eIF4G1 domains were produced from 
plasmids pGEX-4G-GST-eIF4G1(688-1133), pGEX-4G-GST-eIF4G1(688-1560), and 
pGEX-4G-GST-eIF4G1(1075-1560), made by cloning the appropriate eIF4G1 sequences 
into the Sal1 and Not1 sites of pGEX-5x-1. HA-tagged plasmids containing the three 
eIF4G1 domains were made by cloning the appropriate DNA sequences into BamH1 and 
Not1 sites of pcDNA3.1-HA. pGEX4G1404 was used as a template for PCR 
amplification of individual eIF4G1 domains. A plasmid expressing HA-tagged eIF3e was 
generated by inserting the eIF3e open reading frame from the vector pNOp48Nde (from 
John Hershey) into the BamH1 and Not1 sites of pcDNA3.1-HA. A plasmid expressing 
HA-tagged eIF3j in pcDNA5/FRT/HA-p35 was a gift from John Hershey. pFlag-L13a 
was made by cloning full-length L13a ORF into the EcoR1 and BamH1 sites of pFlag-
CMV-5 (Sigma, MO). 
 
Preparation of Recombinant L13a:  pET-17b-L13a and pET-15b-L13a were used to 
express recombinant, unphosphorylated L13a and His-tagged L13a in E. coli (44). 
pFASTBAC1-L13a and pFASTBACHTb-L13a were used to express phosphorylated, 
recombinant L13a and His-tagged L13a in baculovirus-infected insect cells. The 
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construction of these plasmids and protein purification were described previously (44). 
His-tagged L13a was purified by Ni affinity chromatography. 
 
In Vitro Transcription and Translation 
m7G-Luc-GAIT-poly(A) RNA was produced by in vitro transcription using Sp6 
RNApolymerase. PSP64-Luc-GAIT-poly(A) as a template was linearized by PvuII. 
m7G-α-globin-GAIT-poly(A) RNA was made by in vitro transcription of PSP64-α-
globin- GAIT-poly(A) after linearization by EcoR1. The same RNA, but without the 
poly(A) tail, was made by linearization of the same plasmid by Sac1 prior to addition of 
Sp6 RNA polymerase. Sp6 Message Machine kit was used to make m7G-capped 
transcripts. The IRES-containing RNA ApppG-EMCV (or HCV or CrPV)-Luc-GAIT-
poly(A) was made by in vitro transcription using Sp6 RNA polymerase from PvuII-
linearized EMCV(or HCV or CrPV)-Luc-GAIT-poly(A) plasmid. Sp6 Maxiscript kit 
(Ambion) was used with ApppG (unmethylated cap, Ambion) with limiting GTP 
concentration to perform the in vitro transcription reaction. The RNAs were purified by 
LiCl precipitation and washed with 75% ethanol. m7G-T7 gene 10 RNA was made by in 
vitro transcription of pGEMEX-2 (Promega) by T7 RNA polymerase using T7 Message 
Machine kit. PSP64-α-globin-GAIT-poly(A) and PSP64-α-globin-GAIT (mut.)-poly(A) 
plasmids were linearized by either EcoR1 or Sac1. The linearized plasmids were 
transcribed by SP6 RNA polymerase using SP6 Message Machine kit in the presence of 
[α-32P]UTP to generate radiolabeled of m7G-α-globin-GAIT and m7G-α-globin-GAIT 
(mut.) RNA with and without the poly(A) tail. 
 
Purified RNA (200 ng) produced by in vitro transcription was added to RRL (35 
μl) for translation. 20μM methionine-free amino acid mixture, 40 U of RNAsin, 20 μCi 
of translation grade [35S]methionine, and 5 μg of recombinant L13a were also incubated 
in a total volume of 50 μl for 60 min at 30°C. An aliquot (5 μl) was resolved by 7% SDS-
PAGE. The gel was fixed, treated with Amplify (Amersham), dried, and radiolabeled 
bands detected by autoradiography. 
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Sucrose Gradient Fractionation  
In vitro-synthesized RNA (500 ng) was incubated in RRL (100 ml) in the 
presence of 0.5 mM cycloheximide for 5 min at 30°C. The initiation reaction was stopped 
by placing on ice and layerd with a 10%–25% linear sucrose gradient in buffer containing 
100 mM KCl, 5 mM MgCl2, 20 mM HEPES (pH 7.4), 2 mM dithiothreitol, and 0.5 mM 
cycloheximide. After ultra-centrifugation(Beckman) for 16 hrs at 20,000 rpm, the 
gradients were unloaded by upward displacement using a programmable density gradient 
system with a UA-6 detector (ISCO). Fractions were collected, precipitated by TCA and 
followed for western blot analysis.  
To detect the 48S ribosomal complex, 32P-labeled a-globin reporter RNAs (300,000 
cpm) were incubated with RRL (100 ml) in the presence of GMP-PNP (2 mM) or 
cycloheximide (0.5 mM). Reaction products were resolved on a 5%–25% linear sucrose 
gradient by ultra-centrifugation for 18 hrs at 20,000 rpm. Fractions (0.75 ml) were 
collected, and radioactivity was determined by scintillation counting. For eIF3 detection, 
fractions were subjected to TCA precipitation, followed by SDSPAGE and immunoblot 
analysis with anti-eIF3 antibody. 
 
Determination of eIF4F Assembly on GAIT Element-Containing RNA 
m7G-Luc-GAIT-poly(A) or m7G-Luc-GAIT (mut.)-poly(A) RNA (500 ng) was 
incubated with RRL (25 ml) and His-tagged L13a (10 mg) in the presence of 2mM GMP-
PNP at 30°C. After 5 mins, the reaction was terminated with ice-cold buffer containing 
150mM NaCl, 1mM EDTA, 1.5 mM MgCl2, 0.05% Triton X-100, and 50mM HEPES 
(pH 7.5). Immunoprecipitation was done using 10 ml of monoclonal anti-His antibody 
(Novagen). From one aliquot, the GAIT element containing Luc RNA was extracted by 
Trizol (Invitrogen) and subjected to reverse transcription using Luc-specific primers. 
Another aliquot was subjected to SDSPAGE, followed by immunoblot analysis with anti-
eIF4G, anti-eIF4E, 
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CHAPTER III 
RESULTS 
 
P-L13a BLOCKS THE 80S RECRUITMENT                            
Translation initiation reactions of chimeric reporter mRNA containing m7G cap, a 29nt  
Cp mRNA  GAIT element, and a 50 nt poly(A) tail (Luc-GAIT-poly[A]) were 
reconstituted in RRL (rabbit reticulocyte lysate), using luciferase GAIT reporters (Figure 
4A). A construct containing inactive, mutated GAIT element (U87C replacement in the 
3′UTR) was used as an additional control (Luc-GAIT [mut.]-poly[A])  All the reactions 
were performed in the presence of phosphorylated or unmodified L13a. The chimeric 
reporter mRNA was also translated in RRL with T7 gene 10 mRNA as a specificity 
control. Phosphorylated L13a (P-L13a) markedly inhibited translation of Luc-GAIT-
poly(A), but not the reporter containing the mutant element or T7 gene 10 (Figure 1B). 
Unphosphorylated L13a, from E. coli or alkaline phosphatase-treated, insect cell-derived 
L13a was inactive. These results also showed the importance of phosphorylation for L13a 
containing GAIT element mediated silencing. It has been shown that GAIT element-
mediated translational silencing by a U937 cell lysate requires the circularization of 
transcript (48). To examine the requirement of poly(A) tail for P-L13a silencing we 
performed experiments in absence of poly(A) tail. Its absence did not influence the basal 
 12 
 
translation of the Luc-GAIT reporter, however translation of the Luc-GAIT reporter 
containing a poly(A) tail was selectively inhibited by P-L13a (Figure 4C). P-L13a bound 
the Luc reporter irrespective of the presence of a poly(A) tail; however, 
unphosphorylatedL13a did not bind RNA (Figure 4D). Efficient binding of P-L13a to a 
poly(A)-minus reporter indicates that binding is not sufficient for translational silencing, 
but the poly(A) tail may contribute to effective presentation of P-L13a. 
To determine at what stage P-L13a blocks the translation, we began to explore at the 
initiation step, starting with the termination initiation event i.e. the formation of 80S 
ribosome complex. The initiation complexes of chimeric reporter mRNA and P-L13a or 
UnP-L13a were resolved by sucrose density gradient in the presence of cyclohexamide. 
The identity of the 80S peak (Figure 4E, top) was authenticated by RT-PCR amplification 
of 28S and 18S rRNA (Figure 1E, bottom). Reporter RNA was determined by RT-PCR 
amplification using Luc-specific primers. Rapid formation of 80S on the Luc reporter 
containing wild-type or mutant GAIT element was observed (Figure 4F, top). P-L13a 
prevented 80S formation only on a reporter bearing wild-type GAIT element whereas 
unphosphorylated L13a was ineffective (Figure 4F, panels 3–6).  Migration of P-L13a in 
the light, pre-80S fractions was consistent with binding to GAIT element-containing 
RNA and shifting with the RNA to pre-80S fractions (Figure 4F, second panel from 
bottom). Unmodified L13a does not bind the GAIT element reporter, and it is not part of 
an RNP complex; it also migrates in the light fractions (Figure 4F, bottom). Therefore, 
80S formation on GAIT element- containing transcripts is impaired in the presence of P-
L13a, and translation must be blocked at this or an earlier initiation step. 
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Figure 4            
 
 
Figure 4 Translational Silencing by P-L13a Blocks 80S Recruitment to Reporter mRNA 
Containing a GAIT Element 
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(A) Schematic representation of Luc reporter RNAs used in translation initiation 
reactions. 
(B) Translational silencing of GAIT element-containing reporter RNA by P-L13a. Luc 
RNAs (200 ng) were subjected to in vitro translation using [35S]methionine and RRL. T7 
gene 10-poly(A) RNA (100 ng) was cotranslated in the same reaction as control. 
Recombinant P-L13a (5 mg) made by baculovirus-infected insect cells was treated with 
shrimp alkaline phosphatase (3 U) for 90 min. 
(C) Poly(A) tail is required for translational silencing by P-L13a. Luc RNA with T7 gene 
10 RNAs were subjected to in vitro translation by an RRL. Phosphorylated or unmodified 
L13a (5 mg) was added to the in vitro translation reaction. 
(D) Poly(A) tail is not required for L13a recruitment to the GAIT element. Translation 
initiation reactions were reconstituted in RRL, using Luc reporters (500 ng) with or 
without a poly(A) tail, in the presence of His-tagged, phosphorylated or unmodified L13a 
(10 mg). L13a was immunoprecipitated (IP) with monoclonal anti-His antibody, and 
bound RNA was detected by RT-PCR with the Luc-specific primers. 
(E) RNA detection in sucrose density gradient fractions. Initiation reactions were done as 
in (D) in the presence of 0.5mM cycloheximide. The reaction was subjected to sucrose 
density gradient centrifugation using 10%–25% gradient. The 80S peak is marked by a 
horizontal bar. The authenticity of the 80S fractions was confirmed by RT-PCR 
amplification using 28S- (middle) and 18S- (bottom) specific rRNA primers. 
(F) Assembly of 80S ribosome complex. Initiation reactions were done as in (D) and 
subjected to sucrose density gradient centrifugation. Fractions(1 ml) were collected from 
the top. Total RNA was isolated and subjected to RT-PCR using Luc-specific primers 
(top six panels). Migration of P-L13a in the gradient was determined by precipitation of 
the fractions with trichloroacetic acid (TCA), followed by immunoblot (IB) analysis with 
anti-His antibody (bottom two panels). 
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P-L13a BLOCKS THE RECRUITMENT OF 43S RIBOSOME 
COMPLEX TO GAIT ELEMENT BEARING mRNA 
Prior to 80S complex formation, 43S complex is recruited to the 5’cap-bound eIF4F 
complex to form 48S pre-initiation complex. Hence, now we had 2 possibilities: Either P-
L13a blocks 43S recruitment or/And L13a interferes with eIF4F assembly on the target 
mRNA. To determine whether L13a blocks 43S recruitment, we analyzed initiation 
complex assembly in RRL in the presence of a nonhydrolyzable GTP analog, GMP-PNP, 
which prevents 80S formation. In a preliminary characterization, 48S and 80S peaks were 
detected in the presence of GMP-PNP and cyclohexamide, respectively (Figure 5 B).  In 
the presence of GMP-PNP, P-L13a markedly reduced 48S formation on a GAIT element-
containing reporter (Figure 5 C). The inhibition was specific because 48S formation was 
not reduced by unmodified L13a or mutated GAIT element. We made constructs with α-
globin GAIT (WT or MT) reporters with or without the poly(A) tail. P-L13a failed to 
inhibit 48S complex formation on an α-globin reporter RNA carrying the GAIT element 
but lacking a poly(A) tail (Figure 5 C). This result confirms that inhibition of 48S 
formation by P-L13a is poly(A) dependent and suggests an important role for transcript 
closure in the inhibitory process. To further verify the inhibition of 48S formation by P-
L13a, 43S recruitment to target RNAs was determined as an association of eIF3 (43S 
component that binds cap-bound eIF4G) with GAIT element-containing α-globin reporter 
RNA. Addition of P-L13a to the RRL, when a GAIT element reporter RNA was used, 
shifted eIF3 from the 48S fractions to the lower-density RNP fractions whereas in control 
experiments, eIF3 shifting was not observed (Figure 5 D). As eIF4G is required for 48S 
formation, comigration of eIF4G and P-L13a in the sucrose gradients was examined by 
immunoblot analysis. In the presence of GAIT element-containing RNA, but in the 
absence of P-L13a, eIF4G comigrated with 48S complex. However, P-L13a shifted 
eIF4G from the 48S fractions to the low-density, RNP-containing fractions (fig 5 E). 
These results show that P-L13a inhibits 43S recruitment to a transcript containing a 
3’UTR-located GAIT element. Also the inhibition was specific because 48S formation 
was not reduced by unmodified L13a or mutant GAIT element. 
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Figure5  
 
 
Figure 5 P-L13a Blocks the Assembly of 48S Complex 
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(A) Schematic of α-globin RNA constructs used in translation initiation reactions. 
(B) Ribosomal complex formation on GAIT element-containing RNA. Translation 
initiation reactions containing 
32
P-labeled, α-globin-GAIT-poly(A) reporters (300,000 
cpm) were reconstituted in RRL in the presence of GMP-PNP (black, 2 mM) or 
cycloheximide (red, CHX, 0.5 mM) and resolved by sucrose density gradient 
centrifugation. 
(C) P-L13a blocks 48S complex formation on a GAIT element-containing RNA in a 
poly(A)-dependent way. Translation initiation reactions were reconstituted in an RRL 
with GMP-PNP (2 mM) as in (B), but in the presence of His-tagged P-L13a (5 mg). 
Conditions tested were as follows: α-globin-GAIT-poly(A) (red), α-globin-GAIT-poly(A) 
+ L13a (blue), α-globin-GAIT-poly(A) + P-L13a (black), α-globin-GAIT (mut.)-poly(A) 
+ P-L13a (green) and α-globin-GAIT (no poly[A] tail) + P-L13a (orange). The reaction 
was subjected to sucrose density gradient centrifugation, fractions were collected (0.75 
ml), and radioactivity was determined. 
(D) P-L13a prevents formation of eIF3-containing 48S complex. Gradient fractions from 
experiments with a-globin-GAIT-poly(A) reporter and buffer control (top), P-L13a 
(second panel), unmodified L13a (third panel), and other controls (fourth and fifth 
panels) were subjected to TCA precipitation, followed by immunoblot analysis with anti-
eIF3 antibody. Two eIF3 subunits (44 and 110 kDa) are indicated. 
(E) Migration of eIF4G and P-L13a in the sucrose gradient. Gradient fractions from (C) 
containing a-globin-GAIT-poly(A) reporter and buffer control (top) or P-L13a (second 
panel) were subjected to TCA precipitation, followed by immunoblot analysis with anti-
eIF4G antibody. Migration of P-L13a in the presence of a-globin-GAIT-poly(A) (third 
panel), a-globin-GAIT (mut.)-poly(A) (fourth panel), or a-globin-GAIT (bottom) was 
determined by immunoblot analysis with anti-His antibody. 
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ASSEMBLY OF eIF4F IN THE PRESENCE OF P-L13a BOUND RNA 
 
Considering the other possibility of L13a interference with eIF4F assembly, we started 
looking at the assembly of eIF4F complex in the presence or/and absence of P-L13a. 
Initiation of GAIT-element containing reporter RNA was reconstituted in RRL in the 
presence of P-L13a and GMP-PNP (Figure 6 A). Binding was measured by 
immunoprecipitation with anti-His, followed by RT-PCR with Luc-specific primers. P-
L13a bound the RNA target containing Wild type GAIT, but not mutant GAIT element 
(Figure 6 B). Also, as expected for a protein that binds a 3′UTR element, P-L13a binding 
to RNA was not disrupted by interfering with complex assembly at the 5′cap using 
exogenous m7G or human rhinovirus (HRV)-2A protease. To investigate whether eIF4F 
remains bound to L13a-silenced reporter RNA, we identified eIF4F components by 
immunoprecipitation with anti-His antibody and by immunoblot analysis using anti-
eIF4G, -eIF4E, and -eIF4A. All three eIF4F components remained bound to a GAIT 
element reporter in the presence of PL13a (Figure 6 C). The authenticity of the eIF4F 
complex was examined by assessing cap-dependent interaction with the P-L13a silenced 
reporter. Cap dependence was shown by the loss of interaction in the presence of 
exogenous m7G, which blocks eIF4E binding to the cap (Figure 6 C). Furthermore, 
cleavage of eIF4G with HRV-2A protease, which prevents cap-dependent assembly of 
eIF4F, blocked the interaction of P-L13a with eIF4F components eIF4A and eIF4E, while 
permitting a weak interaction with eIF4G (Figure 6 D, top). Thus, P-L13a blocks 43S 
recruitment to GAIT element-bearing transcripts without disrupting eIF4F complex 
assembly and an intact eIF4G is necessary for interaction of P-L13a with eIF4F. 
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Figure 6 
                                 
 
 
Figure 6 Formation of Cap-Binding Complex eIF4F is Not Disrupted by P-L13a 
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(A) Schematic representation of initiation reactions reconstituted on GAIT element-
bearing RNA and subsequent procedures. 
(B) Binding of P-L13a to GAIT element-bearing RNA in RRL. Translation initiation 
reactions were reconstituted in RRL as above. L13a was immunoprecipitated with anti-
His antibody, followed by RT-PCR with Luc-specific primers. 
(C) Analysis of eIF4F components interacting with RNA-bound P-L13a. L13a was 
immunoprecipitated with anti-His antibody, and precipitates were subjected to 
immunoblot analysis with anti-eIF4G (top), anti-eIF4E (second panel), anti-eIF4A (third 
panel) and anti-L13a (bottom) antibodies. 
(D) HRV-2A protease sensitivity of eIF4F complex assembly. Translation initiation 
reaction was reconstituted in RRL with or without HRV-2A protease (2 mg). 
Immunoprecipitation and immunoblot procedures were as in (C). 
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P-L13a TARGETS eIF4G FOR ITS TRANSLATIONAL SILENCING 
ACTIVITY  
 
Our results indicate that L13a blocks initiation at a step after eIF4F assembly on the 
mRNA 50 cap, but before recruitment of 43S complex. Moreover, the presence of eIF4F 
on the silenced transcript suggests that L13a targets an eIF4F constituent. To more 
precisely define the inhibition locus, we took advantage of 5′-situated internal ribosome 
entry sites (IRESs) that initiate translation in the absence of specific eIF4F components. 
Initiation driven by the cricket paralysis virus (CrPV) IRES (31) (32) (33) (34) and 
hepatitis C virus (HCV) IRES (35) supports 43S and 60S recruitment independent of any 
eIF4F component. In contrast, initiation by encephalomyocarditis virus (EMCV) IRES 
requires eIF4A and the central domain of eIF4G, but not cap-binding protein eIF4E (36) 
(37). As expected, translation of capped Luc RNA and T7 gene 10 RNA constructs 
(Figure 7 A) were sensitive to exogenous cap, but translation of RNAs driven by CrPV, 
HCV, and EMCV IRESs were not sensitive (Figure 7 B). Thus, IRES-driven translation 
of GAIT element-bearing reporter RNAs is efficient in an RRL. P-L13a did not inhibit 
CrPV and HCV IRES mediated translation of reporter RNAs, indicating that one or more 
eIF4F components were required (Figure 7 C). In contrast, EMCV IRES-driven 
translation was specifically blocked by P-L13a. The effect of P-L13a on 80S assembly on 
IRES-driven reporters was examined by density gradient fractionation (Figure 3.4 D, 
representative gradient shows EMCV IRES-containing RNA). P-L13a blocked 
association of 80S ribosomes with transcripts driven by EMCV IRES, but not by CrPV or 
HCV IRES (Figure 7 E). These results suggests that an eIF4F component required for 
EMCV IRES-mediated translation, i.e., eIF4G, is required for silencing by P-L13a and 
may be its target. 
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Figure 7 
      
 
  
 
Figure 7 Virus IRES-Driven RNAs Show an eIF4F Component Is Required for 
Translational Silencing by P-L13a 
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(A) Schematic of ApppG-capped, Luc-GAIT element-poly(A) RNAs with CrP, HCV, or 
EMCV IRES sequences. 
(B) In vitro translation of IRES-driven reporters. IRES-driven and m7G-capped reporter 
RNAs (200 ng) were subjected to in vitro translation in RRL in the presence or absence 
of exogenous cap analog, m7G (200 mM). 
(C) Sensitivity of IRES-driven reporters to repression by P-L13a. ApppG-IRES-Luc-
GAIT-poly(A) RNAs (200ng) were subjected to in vitro translation in RRL with capped, 
T7 gene 10-poly(A) RNA (100ng) in the presence of recombinant phosphorylated or 
unmodified L13a (5 mg). 
(D) Ribosomal RNA detection in sucrose density gradient fractions. Initiation reaction of 
IRES-driven Luc RNA reporters (500 ng) was done in the presence of CHX (0.5 mM) 
and subjected to sucrose density gradient centrifugation. A representative 80S peak is 
shown. 
(E) Effect of P-L13a on 80S assembly on IRES-driven RNAs. Initiation reactions of Luc 
RNA-GAIT element reporters (500 ng) driven by m7Gcap (top), CrPV IRES (second 
panel), HCV IRES (third panel), or EMCV IRES (bottom) were reconstituted in RRL in 
the presence of P-L13a (10 mg) and CHX (0.5 mM) and were resolved by sucrose density 
gradient centrifugation. Total RNA isolated from 1 ml fractions was subjected to RT-
PCR analysis using Luc-specific primers. 
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eIF4G DOMAIN FOR TRANSLATIONAL SILENCING BY P-L13a 
 
The eIF4G domain required for translational silencing by P-L13a was investigated. We 
took advantage of HRV-2A protease that cleaves eIF4G in the C terminus near the eIF3-
binding site of the 43S complex (38).The central eIF4G domain permits the EMCV 
IRES-driven translation, and is resistant to HRV-2A protease. (39) (40). EMCV IRES-
containing Luc reporter constructs are shown in Figure 5A. Immunoblot analysis showed 
eIF4G in RRL was cleaved by HRV-2A protease into 110 kDa C-terminal and 72 kDa N-
terminal fragments (Figure 8 B). The identity of the cleavage products were verified by 
antibodies raised against eIF4G N- and C-terminal peptides. EMCV IRES-driven 
translation of the Luc- GAIT-poly(A) reporter was unaffected by eIF4G cleavage, but 
translation of cap-driven T7 gene 10 was blocked (Figure 8 C, lane 3). P-L13a blocked 
translation of EMCV IRES-driven reporter even after protease cleavage of eIF4G (Figure 
8 C, lane 6).  These results implicate the C-terminal domain of eIF4G as the L13a target. 
The inhibition of EMCV IRES-driven translation by P-L13a was poly(A) tail dependent 
(Figure 8 D, lanes 3 and 9). Interestingly, the inhibition of translation was poly(A) tail 
independent when eIF4G was cleaved with HRV-2A protease (Figure 8 D, lanes 6 and 8). 
Taken together, these results suggest the importance of intact eIF4G for  
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     Figure8           
 
 
Figure 8. eIF4G C-Terminal Domain Is Necessary and Sufficient for Translational 
Silencing by P-L13a 
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(A) Schematic of ApppG-capped, Luc-GAIT element RNAs. 
(B) Cleavage of RRL eIF4G by HRV-2A protease. Recombinant HRV-2A protease (2 
mg) was incubated with RRL (100 mg) for 30 mins at 37°C and subjected to SDS-PAGE 
and immunoblot analysis with anti-eIF4G antibody raised against peptide sequences from 
N (aminoacids 175–200) and C (amino acids 1179– 1206) termini of eIF4G1.     
(C) Inhibition of EMCV IRES-driven translation by P-L13a in the presence of HRV-2A 
protease. ApppG-capped Luc RNA (200 ng) containing GAIT element with EMCV IRES 
and m7G-capped T7 gene 10 RNA (above) were translated in RRL with phosphorylated 
or unmodifiedL13a, and in the presence or absence of exogenous m7G cap and HRV-2A 
protease. (D) Inhibition of EMCV IRES-driven translation by P-L13a is poly(A) 
independent when eIF4G is cleaved. Translation was done as in (C) in the presence or 
absence of phosphorylated L13a and HRV-2A protease. 
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L13a INTERACTS WITH eIF4G AT ITS eIF3 BINDING SITE 
 
Our co-immunoprecipitation studies in vitro suggest that L13a interacts with eIF4G in 
RRL (Figure 6C). The interaction was also investigated in vivo, human embryonic 293T 
kidney (HEK 293T) cells transfected with a vector driving expression of Flag tagged 
L13a. Immunoprecipitation with anti-Flag antibody, followed by an immunoblot with 
anti-eIF4G antibody, showed specific interaction of L13a with eIF4G (Figure9 A). The 
eIF4G domain that binds L13a was investigated using HRV-2A protease to cleave eIF4G. 
His-tagged P-L13a was added to HRV-2A pretreated RRL, L13a was 
immunoprecipitated with anti-His antibody and probed with anti-eIF4G. P-L13a 
interaction with the C terminus of eIF4G was shown by co-immunoprecipitation of a 110 
kDa, C-terminal fragment (Figure 9 B). The L13a interaction site was investigated by co-
transfection of 293T cells with Flag- tagged L13a and vectors expressing HA-tagged 
eIF4G domains overlapping the initiation factor-binding sites (Figure 9 C). L13a co-
immunoprecipitated with eIF4G(688–1560) and eIF4G(970–1560), but not with 
eIF4G(1075–1560) (Figure 9 D, top). Controls showed uniform expression of Flag-L13a 
(Figure 9 D, middle) and all eIF4G deletion fragments (Figure 9 D, bottom).  
 
The eIF3-binding site in eIF4G, between amino acids 975 and 1065, is present in 
eIF4G(970–1560) but not in eIF4G(1075–1560), indicating that this domain is critical for 
L13a binding. To verify the importance of this interaction in translational silencing, 
dominant- negative activity of eIF4G deletion fragments was determined. C-terminal 
eIF4G fragments were expressed as GST fusion proteins in E. coli (Figure 9 C), 
preincubated with recombinant P-L13a, and added to an in vitro translation reaction 
driven by m7G-Luc-GAIT-poly(A) RNA. eIF4G(688–1131) and eIF4G(688–1560) 
blocked translation repression by P-L13a, but eIF4G(1075–1560) was ineffective (Figure 
9 E, top). Fusion proteins added in the absence of P-L13a were inactive (Figure 9 E, 
bottom). Thus, only eIF4G fragments containing the eIF3-binding site inhibited P-L13a 
activity, indicating that eIF3 and L13a share the same or neighboring binding sites on 
eIF4G. To test whether P-L13a competes with eIF3 for binding to eIF4G, we took 
advantage of the finding that the eIF3e subunit of eIF3 binds with high affinity to eIF4G 
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and is required for 43S recruitment (41). U937 cells were transfected with plasmids 
expressing HA tagged eIF3e and eIF3j (as negative control) and were treated with IFN-γ 
for 20 hr. Overexpression of eIF3e, but not eIF3j, substantially blocks the inducible 
binding between L13a and eIF4G as determined by co-immunoprecipitation (Figure 9 F, 
top). Control studies show nearly equivalent expression of transfected eIF3 subunits 
(Figure 9F, middle) and consistent immunoprecipitation of L13a under all conditions 
(Figure 9 F, bottom). These results suggest that competition of P-L13a with eIF3e for 
binding to eIF4G is the mechanism by which L13a blocks 43S recruitment and silences 
translation. 
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 Figure9 
 
 
Figure 9.       L13a and eIF3 Shares a Common eIF4G-Binding Site 
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(A) L13a binds eIF4G in 293T cells. 293T cells were transfected with pcDNA3-Flag-
L13a or pcDNA3-Flag constructs. After 20 hrs, cell extracts were prepared and subjected 
to immunoprecipitation with anti-Flag antibody. The immunoprecipitations were resolved 
by SDS-PAGE, followed by immunoblotting with anti-eIF4G antibody. 
(B) L13a binds the C-terminal fragment of eIF4G. eIF4G in RRL was cleaved by HRV-
2A protease. His-tagged P-L13a was incubated with RRL in the presence or absence of 
HRV-2A protease, followed by immunoprecipitation with anti-His antibody and 
immunoblotting with anti-eIF4G antibody, or SP2/O as control antibody (top). 
Immunoprecipitation efficiency was shown by reprobing the blot with anti-L13a antibody 
(bottom). 
(C) Schematic showing eIF4G deletion fragments made as GST fusion proteins or HA-
tagged protein is indicated below. 
(D) Mapping the interacting domain/s of eIF4G with L13a. 293T cells were cotransfected 
with Flag-L13a and HA-tagged eIF4G(688–1560), eIF4G(970–1560) or eIF4G(1075–
1560). Cell lysates were immunoprecipitated with anti-Flag antibody, then were resolved 
by SDS-PAGE and subjected to immunoblot analysis with anti-HA (top) or with anti-
Flag (middle) antibodies. Aliquots of lysates without immunoprecipitation were probed 
by immunoblot with anti-HA antibody (bottom). 
(E) Exogenous eIF4G C-terminal fragment overcomes repression by P-L13a. P-L13a (5 
mg) was preincubated with partially purified GST fusion proteins (50 mg) eIF4G(688–
1131), eIF4G(688–1560), and eIF4G(1075–1560) and with GST control protein. 
Preincubated solutions were added to RRL, and cap-Luc-GAIT element-poly(A) (200 ng) 
and T7 gene 10-poly(A) were subjected to in vitro translation (top). As a control, partially 
purified GST fusion proteins containing eIF4G domains were added to in vitro translation 
reaction in the absence of P-L13a (bottom). 
(F) Overexpression of eIF3e blocks binding of L13a to eIF4G. U937 cells were 
transfected with HA-tagged eIF3e or eIF3j by electroporation using Amaxa method. 
U937 cells (53106) were treated with IFN-γ for 4 or 20 hrs. Cell lysates were subjected to 
immunoprecipitation with anti-L13a antibody and immunoblotting with anti-eIF4G (top), 
anti-HA (middle), or anti-L13a (bottom) antibodies.  
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CHAPTER IV 
 
DISCUSSION 
 
 
We have determined a molecular mechanism by which the inflammatory protein 
Cp is translationally silenced in cells in response to prolonged treatment with IFN-γ. This 
repression is important because uncontrolled Cp expression may have injurious 
consequences due to the oxidative properties of the copper protein (42) (43). Here, we 
show that L13a is the GAIT complex protein directly responsible for translational 
silencing of Cp mRNA and possibly other target transcripts. 
 
 
Transcript Circularization and Other Requirements for Silencing 
Activity of L13a 
We took advantage of our previous findings, that recombinant L13a produced by 
baculovirus-infected insect cells is phosphorylated and active in an in vitro translation 
assay, whereas recombinant L13a from E.coli is unmodified and inactive (44). L13a 
phosphorylation is required for the GAIT complex mediated inhibition, and the RRL 
itself likely contributes the other three GAIT proteins that are all constitutive products of 
‘‘housekeeping’’ genes. The requirement for a poly(A) tail on the target transcript is of 
substantial interest. In addition to its role in cap dependent translation, the poly(A) tail 
enhances the translation of EMCV IRES, indicating a possible communication between 5′ 
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and 3′ termini during IRES-mediated translation (45), (46), (47). Therefore, it is not 
unexpected that P-L13a silences EMCV IRES-driven translation of GAIT element-
containing RNA. However, our finding that P-L13a silences EMCV IRES-mediated 
translation even after the cleavage of eIF4G was surprising because the remaining C-
terminal fragment of eIF4G does not bind to PABP (Poly(A)) binding protein) or 
facilitate end-to-end interaction. A possible explanation is that P-L13a has a very high 
affinity for the C terminus of the cleaved eIF4G fragment that remains bound to the 
EMCV IRES, and this high-affinity binding may compensate for the loss of mRNA 
circularization in the absence of a poly(A) tail. This possibility is consistent showing 
equal efficiency of translation of EMCV IRES driven mRNAs with and without poly(A) 
tails under the conditions of eIF4G cleavage by HRV-2A protease (47). In both cases, 
eIF4G cleavage causes translation (or repression) of EMCV IRES-driven mRNAs to be 
poly(A) independent. The efficient translation they observed may be due to increased 
affinity of eIF3e for the cleaved eIF4G fragment, which overcomes the need for the 
poly(A) tail. We speculate that, in our studies, P-L13a (which shares with eIF3e the same 
eIF4G-binding site) may also have an increased affinity for cleaved eIF4G, which 
similarly overcomes the requirement for a poly(A) tail. 
 
Our results show that the poly(A) tail is not necessary for binding P-L13a to the 
GAIT element (Figure 4D), but rather it is necessary for end-to-end transcript closure by 
a succession of interactions with PABP and eIF4G (48). Similarly, a recent report on 
translational repression by miRNA shows that activity of the inhibitory, 3′UTR-binding 
miRNP complex requires target mRNA polyadenylation (49). Transcript closure may be 
necessary to carry P-L13a from the distal 3′UTR into the vicinity of the 5′-localized 
translation initiation complex where it exerts its inhibitory activity. Our new result 
showing the eIF4F complex remains intact on a silenced transcript is consistent with this 
mechanism.  
 
P-L13a Targets eIF4G for Transcript-Specific Translation Inhibition 
eIF4G is an essential initiation factor for protein translation. It is a component of 
the cap-binding complex eIF4F, facilitates end-to-end transcript interactions, acts as a 
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scaffold for RNA-unwinding proteins and other initiation factors, and makes initial 
contact with the ribosome via its interaction with eIF3 of the 43S complex. The central 
position of eIF4G and its multiple interactions makes it a strategic target for translation 
regulation. In fact, eIF4G is a target, common to multiple pathways that inhibit global 
protein synthesis, e.g., cell responses to virus infection, apoptosis, and stress (Figure 
10a). Most silencing mechanisms that target eIF4G ultimately leads to global inhibition 
of cap – dependent protein synthesis. For example, eIF4G is proteolytically cleaved upon 
virus infection by viral proteases like 2A protease encoded by poliovirus, rhinovirus and 
cox – sackie virus, and L protease encoded by foot-and-mouth disease virus (50). 
Simlarly, caspase – 3 cleaves eIF4G in apoptotic cells (51) (52). Other viral and cellular 
proteins bind eIF4G and inactivate it without cleavage, e.g., adenovirus 100-kDa protein 
binds eIF4G and displaces Mnk1, an eIF4E kinase that activates translation (53). NSP3 
protein of rotavirus (54) and NS1 protein of influenza virus (55) bind the eIF4G N 
terminus and displaces PABP. Upon heat shock or other cell stress, the Hsp27chaperone 
protein binds eIF4G and traps it in insoluble complexes (56). In all the above examples, 
eIF4G is the targeted by RNA–independent mechanism to cause global inhibition of 
translation. Our results reveal that eIF4G is also a target for RNA–specific translation 
silencing by L13a (Figure 10b). 
  
However, there are several aspects of the inhibition by L13a that differentiate it 
from global mechanisms. The requirement for a specific structural element makes this 
inhibitory mechanism transcript specific rather than global. Moreover, unlike most global 
inhibitors of translation, P-L13a does not alter initiation factors by proteolysis or by 
disruption of assembled complexes; translation inhibition by P-L13a occurs in the 
presence of an intact eIF4F complex. Our studies with HRV-2A protease fragments show 
that L13a binds the eIF4G C terminus. Detailed analysis of the binding site shows that 
L13a and eIF3 share the same binding site on eIF4G. We also observed that non P-L13a 
binds weakly to eIF4G in RRL even in the absence of RNA suggesting that L13a binds 
free eIF4G i.e. not associated with eIF4F complex with low affinity. But the binding to 
eIF4G is enhanced when it is associated with cap-bound eIF4F complex and when L13a 
is phosphorylated and bound to 3’UTR of mRNA as part of GAIT complex. 
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Overexpression of eIF3e (one of the subunit of eIF3), which exhibit high-affinity binding 
to eIF4G (41), blocks this interaction, supporting a model in which GAIT element-bound 
P-L13a and 43S-bound eIF3 compete for binding to cap-bound eIF4G. Unexpectedly, 
non-phosphorylated L13a binds weakly to eIF4G in an RRL even in the absence of RNA 
(Figure 6 C). Under this condition, L13a interacts with eIF4G, but not eIF4E or eIF4A, 
suggesting L13a binds free eIF4G not associated with the eIF4F cap-binding complex. In 
summary, L13a binds free eIF4G with low affinity, but binding is enhanced when eIF4G 
is associated with cap-bound eIF4F. Binding to eIF4G may be increased further when 
L13a is phosphorylated and bound to the transcript 3′UTR as a part of the GAIT complex 
(20). 
 
Other Mechanisms that express Transcript-Specific Translational 
Control 
Only a few systems of mRNA-specific translational control have been elucidated 
at the molecular level. However, it is already apparent that diverse mechanisms have 
evolved that inhibits initiation at multiple steps (57). The specific inhibitory mechanism 
driven by L13a has unique characteristics that differentiate it from previously described 
translation initiation regulators. P-L13a inhibiting the 43S recruitment distinguishes it 
from mechanisms in which initiation is blocked after 43S recruitment to the mRNA. For 
example, SXL binds to a poly(U)-rich region in the 5′UTR of msl-2 mRNA in D. 
melanogaster and inhibits 43S ribosome scanning (58). In a second example, binding of 
hnRNPs K and E1 to the 3′UTR DICE element of reticulocyte 15-lipoxygenase inhibits 
60S ribosomal subunit joining to the 43S subunit (59). Inhibition of 43S recruitment has 
been reported for several translation regulators; however, their inhibitory mechanisms are 
distinct from that used by L13a. A complex containing cytoplasmic polyadenylation 
element binding protein (CPEB) and maskin binds the cytoplasmic polyadenylation 
element in the 3′UTR of target mRNAs during vertebrate oocyte development and 
silences their translation. The CPEB-maskin complex binds eIF4E and prevents its 
interaction with eIF4G, and thus blocks eIF4F assembly (60).  
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Our finding that a 3′UTR-bound inhibitory complex (GAIT) targets eIF4G and 
blocks 43S recruitment provides a new mechanism of transcript-specific translational 
repression. The presence of an intact eIF4F cap-binding complex, despite the interaction 
of L13a and eIF4G, is a notable feature that differentiates this mechanism from those in 
which attack on eIF4G prevents eIF4F assembly. Because of an integral eIF4F complex, 
the eIF4G component facilitates end-to-end transcript closure that is required for 
translation inhibition by L13a. In other cases in which eIF4E is targeted, 5′ to 3′ transcript 
interactions are mediated by the trans-acting factors themselves, not by the poly(A) tails. 
Thus, the requirement for an intact eIF4F complex for L13a-mediated repression may be 
related to the poly(A) dependency of the mechanism. It will be of interest to learn 
whether the requirement for an intact eIF4F is a common feature in translational control 
mechanisms that, like L13a, are poly(A) dependent and target general initiation factors. 
 
Figure 10 Global and Transcript-Specific Translational Silencing targeting eIF4G 
      
     
          (Kapasi et al., 2007, ref #20) 
 
(A) Global inhibition of translation by targeting eIF4G. Virus infection, apoptosis, and 
cell stress target eIF4G by different mechanisms. 
(B) L13a targets eIF4G for transcript-specific inhibition of translation. L13a in the 
3′UTRbound GAIT complex targets eIF4G without cleavage of eIF4G or disruption of 
cap-binding eIF4F complex. Binding of P-L13a to the eIF3-binding site of eIF4G blocks 
interaction of 43S ribosomal complex and represses translation. 
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